Tim Brier - AstraZeneca | LinkedIn
Big pharma-based physician with GMC specialist registration in both clinical pharmacology… · Experience: AstraZeneca · Education: King's College London · Location: London Area, …
- Connections: 113
- Location: AstraZeneca
Tim Brier - Google Scholar
AstraZeneca - Cited by 1,299 - Early Phase Clinical Trials - Oncology clinical trials
Abstract P3-07-28: SERENA-1: Updated analyses from a Phase 1 …
Background: SERENA-1 (NCT03616587) is a Phase 1, multi-part, open-label study of camizestrant in women with ER+/HER2− advanced breast cancer.
Serena-1: Updated analyses from a phase 1 study (parts C/D) of …
Jun 2, 2022 · Background: SERENA-1 (NCT03616587) is a Phase 1, multi-part, open-label study of camizestrant in women with ER+, HER2− advanced breast cancer (ABC). Parts A/B …
Welcome to the Population Approach Group in Europe
4) Late Development, Oncology R&D, AstraZeneca, Cambridge, UK. Introduction/Objectives: Camizestrant (AZD9833) is a next-generation oral selective estrogen receptor (ER) degrader …
• This study was funded by AstraZeneca. AstraZeneca develops and markets treatments for breast cancer. Camizestrant is an investigational medical product with no currently approved …
Tim Brier's research works
Tim Brier's 9 research works with 129 citations, including: 754P Initial results from a first-in-human study of AZD5335, a folate receptor α (FRα)-targeted antibody-drug conjugate, in...
Abstract P3-07-13: The next generation oral selective estrogen …
Mar 1, 2023 · The SERENA-6 trial is investigating the efficacy and safety of camizestrant plus a CDK4/6 inhibitor in patients with metastatic breast cancer and detectable ESR1m. We …
Meeting Abstract: 2020 ASCO Annual Meeting I - ASCO Publications
May 25, 2020 · International retrospective cohort study of locoregional and systemic therapy in oligometastatic breast cancer (OLIGO-BC1). Background: AZD9833 is an oral selective …
Tim Brier - AD Scientific Index 2023
Tim Brier AD Scientific Index 2023 AstraZeneca, Sweden. AstraZeneca. Registration - Add Profile, Subject etc. print Print Your Certificate SCORES RANKINGS; In AstraZeneca, Sweden …